Botox is often discussed as a single treatment, but its effects depend almost entirely on where it is placed and which ...

The FDA just approved a unique botulinum toxin A (BoTX-A) called DAXXIFY™ that lasted an average of six months in research subjects. I performed the research trials that led to its FDA approval, so I ...

One of the first signs of growing older are frown lines between the eyebrows. Millennials, it seems, want none of that. As far back as 2016, Modern Aesthetics had reported that “millennials consider ...

A new antiwrinkle drug threatens Botox’s three-decade dominance of the facial injectables market. The challenger is DaxibotulinumtoxinA-lanm or Daxxify, a neuromodulator protein that, like Botox, can ...